Published On: Wed, Oct 19th, 2016

HTG Molecular Diagnostics, Inc. (HTGM) Updated Broker Ratings


A number of investment brokers have recently updated their price targets on shares of HTG Molecular Diagnostics, Inc. (HTGM).

Most recent broker ratings

10/12/2016 – HTG Molecular Diagnostics, Inc. had its “buy” rating reiterated by analysts at H.C. Wainwright. They now have a USD 5 price target on the stock.

08/22/2016 – Rodman & Renshaw began new coverage on HTG Molecular Diagnostics, Inc. giving the company a “buy” rating. They now have a USD 5 price target on the stock.

04/04/2016 – HTG Molecular Diagnostics, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 7 price target on the stock.

03/28/2016 – HTG Molecular Diagnostics, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 5 price target on the stock.

06/03/2015 – JMP Securities began new coverage on HTG Molecular Diagnostics, Inc. giving the company a “market outperform” rating. They now have a USD 21 price target on the stock.

The share price of HTG Molecular Diagnostics, Inc. (HTGM) was down -12.33% during the last day of trading, with a day high of 3.03. 283495 shares were traded during the last session.

The stock’s 50 day moving average is 2.51 and its 200 day moving average is 2.65. The stock’s market capitalization is 18.54M. HTG Molecular Diagnostics, Inc. has a 52-week low of 2.03 and a 52-week high of 6.03.

HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company’s HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company’s HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company’s HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.